N. Vemuri

CMS : the TriDAS Project Technical Design Report; v.1, the Trigger Systems

João Paulo Teixeira, Marcelino B. Santos, Rita Almeida Ribeiro, 2004 .

Lipid Nanocarrier-Mediated Drug Delivery System to Enhance the Oral Bioavailability of Rifabutin

Neeraj Kumar, G. Khuller, N. Vemuri, 2017, AAPS PharmSciTech.

Antisphingolipid antibodies in the sera of leprosy patients.

N. Vemuri, S. Gangal, R. Mukherjee, 1996, Leprosy review.

Dysregulation of IL-4 expression in lepromatous leprosy patients with and without erythema nodosum leprosum.

V. Ramesh, N. Vemuri, M. Colston, 2000, Leprosy review.

Immunoreactivity of nerve lipid antigens in leprosy

N. Vemuri, R. Mukherjee, Nalini Vemuri, 1991, Journal of clinical laboratory analysis.

The effect of antigen presenting cells on the cytokine profiles of stable and reactional lepromatous leprosy patients.

V. Ramesh, N. Vemuri, S. Jain, 2000, Immunology letters.

Efficacy of moxifloxacin & econazole against multidrug resistant (MDR) Mycobacterium tuberculosis in murine model

U. Gupta, G. Khuller, N. Vemuri, 2015, The Indian journal of medical research.

Nanoformulations of Moxifloxacin, Econozole and Ethionamide as Novel Treatment Regimens Against MDR TB - An Experimental Study

U. Gupta, G. Khuller, N. Vemuri, 2015 .